- Home
- ENLT vs BAX Comparison
ENLT vs BAX Comparison
Compare ENLT & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ENLT | BAX |
|---|---|---|
| Founded | 2008 | 1931 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5B | 10.2B |
| IPO Year | 2022 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ENLT | BAX |
|---|---|---|
| Price | $90.23 | $17.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 9 |
| Target Price | ★ $48.83 | $21.00 |
| AVG Volume (30 Days) | 141.9K | ★ 7.5M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $403.69 | $1.96 |
| Revenue Next Year | N/A | $2.22 |
| P/E Ratio | $76.10 | ★ N/A |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $16.88 | $15.73 |
| 52 Week High | $93.85 | $32.04 |
Technical Indicators
Market Signals| Indicator | ENLT | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 59.67 | 52.66 |
| Support Level | $65.61 | $17.69 |
| Resistance Level | N/A | $18.97 |
| Average True Range (ATR) | 3.14 | 0.73 |
| MACD | -0.21 | -0.03 |
| Stochastic Oscillator | 73.18 | 56.22 |
Price Performance
Historical ComparisonAbout ENLT Enlight Renewable Energy Ltd.
Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, producing its revenue from the sale of the electricity which is produced through wind energy and solar energy in Europe.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.